Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcadia Biosciences (RKDA) Income from Non-Controlling Interests (2020 - 2023)

Historic Income from Non-Controlling Interests for Arcadia Biosciences (RKDA) over the last 4 years, with Q2 2023 value amounting to -$5000.0.

  • Arcadia Biosciences' Income from Non-Controlling Interests rose 7500.0% to -$5000.0 in Q2 2023 from the same period last year, while for Jun 2024 it was -$5000.0, marking a year-over-year increase of 9494.95%. This contributed to the annual value of -$5000.0 for FY2023, which is 9788.14% up from last year.
  • According to the latest figures from Q2 2023, Arcadia Biosciences' Income from Non-Controlling Interests is -$5000.0, which was up 7500.0% from -$84000.0 recorded in Q4 2022.
  • In the past 5 years, Arcadia Biosciences' Income from Non-Controlling Interests registered a high of -$5000.0 during Q2 2023, and its lowest value of -$774000.0 during Q3 2020.
  • Over the past 4 years, Arcadia Biosciences' median Income from Non-Controlling Interests value was -$161000.0 (recorded in 2021), while the average stood at -$239307.7.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first plummeted by 26960.78% in 2021, then surged by 9848.71% in 2022.
  • Arcadia Biosciences' Income from Non-Controlling Interests (Quarter) stood at -$290000.0 in 2020, then fell by 3.45% to -$300000.0 in 2021, then soared by 72.0% to -$84000.0 in 2022, then soared by 94.05% to -$5000.0 in 2023.
  • Its Income from Non-Controlling Interests was -$5000.0 in Q2 2023, compared to -$84000.0 in Q4 2022 and -$10000.0 in Q3 2022.